Proactive - Interviews for investors cover logo

Orthocell reports 98.6% success rate in Striate+™ dental membrane study

5m · Proactive - Interviews for investors · 15 May 03:41

Orthocell Ltd (ASX:OCC, OTC:ORHHF) CEO and managing director Paul Anderson joins Jonathan Jackson in the Proactive studio to talk through a 98.6% success rate in a post-market clinical study examining the effectiveness of its Striate+™ dental membrane in guided bone regeneration for dental implants. The Striate+™, a resorbable collagen membrane, has been validated through this study as a leading solution in bone and tissue regeneration, supporting Orthocell’s claim of its product being the best choice for such medical procedures. Anderson highlights the membrane's ability to enable high-quality bone and tissue repair, crucial for functional and aesthetically pleasing outcomes in patients. These results, indicating a notable level of bone formation and stability, were obtained from 99 patients, reinforcing the product's efficacy in real-world applications. Orthocell anticipates that the success of the Striate+™ will enhance its visibility among dental professionals and support BioHorizons, its exclusive global distributor, in increasing the product's market adoption. This development is particularly significant given the estimated annual market potential of more than US$700 million for the Striate+ product. The findings are scheduled for presentation at the European Association for Osseintegration (EAO) annual meeting in October 2024. The study also contributes to the clinical data needed for re-certification of EU market approval under the new European Medical Device Regulations (MDR), following an earlier Post-Market Clinical Follow-up (PMCF) study. #ProactiveInvestors #Orthocell #ASX #OTC #DentalImplants, #BoneRegeneration, #StriatePlus, #DentalSurgery, #MedicalDevices, #ClinicalStudy, #TissueRepair, #BioHorizons, #EAO2024, #DentalHealth, #GuidedBoneRegeneration, #CollagenMembrane, #DentalCare, #Osseointegration, #EURegulations, #MedicalResearch, #HealthcareInnovation, #PatientCare, #MedicalTechnology #invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews

The episode Orthocell reports 98.6% success rate in Striate+™ dental membrane study from the podcast Proactive - Interviews for investors has a duration of 5:52. It was first published 15 May 03:41. The cover art and the content belong to their respective owners.

More episodes from Proactive - Interviews for investors

Latrobe Magnesium raises $18 million for Demonstration Plant and future expansion

Latrobe Magnesium Ltd (ASX: LMG) chief operating officer Ronan Gillen sits down with Jonathan Jackson in the Proactive studio to discuss the firm commitments received to raise A$12 million from new and existing institutional and professional investors via an institutional placement, alongside a proposed fully underwritten, non-renounceable entitlement offer to raise A$6 million. Funds will be utilised for the final structural works and commissioning of the Demonstration Plant, final engineering for steady-state production of 1,000 tonnes per annum magnesium metal and ongoing R&D in partnership with CSIRO. The offer received strong support from LMG’s directors and management, who subscribed for A$650,000 of shares. Gillen expressed satisfaction with the support, noting the demand from both domestic and international markets. He highlighted the significance of LMG being the first to produce magnesium from brown coal fly ash and the positive macroeconomic outlook for magnesium. The raised funds will support the Demonstration Plant in producing magnesium metal and saleable by-products, showcasing the commercial viability of their full flowsheet. LMG is also advancing plans for a 10,000 tonnes per annum Commercial Plant, with a bankable feasibility study set to begin shortly and inform a Final Investment Decision by the end of the year. The placement offers an opportunity to diversify the shareholder register ahead of significant company growth. #ProactiveInvestors #LatrobeMagnesium #ASX, #EquityRaising, #InstitutionalPlacement, #EntitlementOffer, #MagnesiumProduction, #DemonstrationPlant, #CSRIO, #StructuralWorks, #Engineering, #R&D, #DavidPaterson, #InvestorSupport, #CommercialPlant, #FeasibilityStudy, #InvestmentDecision, #Shareholders, #FlyAsh, #MagnesiumIndustry, #Innovation #invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews

Intelligent Monitoring Group announces strategic acquisitions of AAG and ACG

Intelligent Monitoring Group Ltd (ASX:IMB) joins Jonathan Jackson in the Proactive studio to discuss binding agreements to acquire Everjazz Pty Limited (Alarm Assets Group or AAG) and ACG Integration Pty Ltd (ACG) for a total of $15.9 million. These acquisitions are anticipated to add $5.7 million to FY24 proforma EBITDA, at an EV/EBITDA multiple of 2.8x. The acquisitions will bring more than 35 skilled technicians and expand IMG’s national coverage, enhancing capacity for growth in its commercial business. The client bases of AAG and ACG include ASX 100 companies and large government clients. To fund the acquisitions, IMG will issue approximately 60.4 million new shares at $0.32 each, raising about $19.3 million. This represents a 7.2% discount to the last closing price and a 0.4% discount to the 10-day volume-weighted average price. The proceeds will cover acquisition costs, transaction expenses and working capital requirements. Completion of the acquisitions is subject to various conditions, including financier approval, and is targeted for June 30, 2024. Hambling highlighted the acquisitions as strategic additions to ADT’s business, projecting a revenue run rate increase to $12 million annually by June 2024, with further growth anticipated. #ProactiveInvestors #IMG #ASX #Acquisitions #SecurityServices #BusinessGrowth #Investment #ASX #Technicians #CommercialBusiness #EBITDA #EquityPlacement #StrategicGrowth #ADT #NewShares #InstitutionalInvestors #NationalCoverage #RevenueGrowth #SecurityIndustry #InvestorSupport #Refinancing #Australasia #invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews

Li-S Energy advances Phase 3 production, achieves safety milestones

Li-S Energy Ltd (ASX:LIS) CEO Dr Lee Finniear sits down with Proactive’s Jonathan Jackson to discuss the company’s achievements and the importance of lithium sulphur batteries in the race to carbon zero. Finniear discusses the advancements the company is making with the technology and why lithium sulphur is better than lithium ion? During the last quarter, Li-S Energy advanced the commissioning of its Phase 3, 2MWh cell production facility and successfully produced the first 20-layer lithium sulphur sample cells. The commissioning process, although complex, is progressing without insurmountable challenges. The company is now testing these sample cells for quality, construction, performance, consistency and safety to optimise each manufacturing step. This process is crucial for refining the cell design and manufacturing precision before mass production. The final cell design will be self-certified to UN38.3 standards for safe international transportation. Li-S Energy conducted nail penetration tests on 28 2.5Ah multi-layer lithium sulphur cells, built on the Phase 2 micro-production line. These cells passed the civilian UL2271 & UL2580 standards and the United States Military Performance Specifications MIL-PRF-32383/4X, without fire, explosion, leakage or overheating. The company also filed two new provisional patents and hosted Bob Galyen, former CTO of CATL, at their Geelong facility. Additionally, meetings with Federal and State government officials emphasised the importance of sovereign battery manufacturing capability. Visits to partners like Magnix Aero and ongoing negotiations with prospective partners were also noted.

Wishpond Q1 results include revenue growth and 39% increase in adjusted EBITDA

Wishpond Technologies CEO Ali Tajskandar and CFO David Pais joined Steve Darling from Proactive to announce the company's consolidated financial statements for Q1 2024, representing the three months ended March 31, 2024. Wishpond achieved quarterly revenue of $6,050,263 in Q1 2024, an 8% increase from $5,623,817 in the same period of 2023. This revenue growth was primarily driven by organic growth, increased sales and marketing activities, and new product introductions. The company reported a gross profit of $4,128,922 in Q1 2024, a 12% increase from Q1 2023. Wishpond's gross margin percentage for Q1 2024 was 68%. The company achieved positive Adjusted EBITDA of $290,304 in Q1 2024, a 39% increase from Q1 2023. Wishpond has over $2 million in cash on hand, with the reduction in net cash due to earnout payments for businesses acquired in 2022, investments in the business, and changes in working capital. The company also announced the beta launch of its proprietary AI-powered sales platform, SalesCloser AI. The beta program has already seen several hundred businesses sign up. The platform can work 24/7 to engage leads, close deals, and service customers in ten different languages. SalesCloser can be adapted for use across various industries, including software/SaaS, professional services, financial services, education, travel and hospitality, insurance, and more. Wishpond expects to achieve record revenue and Adjusted EBITDA in 2024, driven by the increasing traction of its new Propel IQ bundled product, an expanded sales team, and new sales from the recently launched SalesCloser AI virtual agent. The company continues to have an active pipeline of sales opportunities and robust demand for its products. #proactiveinvestors #wishpondltd #tsxv #wish #otcqx #wpndf #Q12024Results #RevenueGrowth #SalesCloser #PropellerIQ #EBITDA #FinancialResults #TechCompany #CostManagement #BusinessGrowth #InboundInterest #ProductDevelopment #Seasonality #RevenueDriver #AdjustedEBIT #FinancialPerformance #TechInnovation #MarketExpansion #CashFlow #CustomerRetention #invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews

North Bay Resources Confirms Nickel-Cobalt Deposit at Tulameen Platinum Project

North Bay Resources CEO Jared Lazerson joined Steve Darling from Proactive to announce the latest exploration results from the Tulameen Platinum Project in British Columbia. The company has received assays from recent exploration efforts, revealing significant findings. Nine rock samples were analyzed using Aqua Regia - ICP whole rock analyses, confirming a magnesium-hosted nickel-cobalt deposit with additional copper and platinum group metals. Lazerson elaborated that the Tulameen property is known for hosting a large magnesium deposit, primarily consisting of olivine within a dunite core. Dunite is a common host rock and indicator for nickel, as well as other valuable metals and gems. Historical exploration by Diamet in the 1980s estimated the presence of 15,000,000 tons of dunite in a single zone, mainly in the form of olivine. Moreover, four additional zones have been identified on the property, indicating a substantial mineralization potential. These findings mark a significant milestone for North Bay Resources as they confirm the presence of a multi-metal deposit, which includes valuable nickel and cobalt resources. The confirmation of platinum group metals adds further value to the project, highlighting its potential as a significant source of critical minerals. Lazerson emphasized that the positive assay results support the company's strategic focus on advancing the Tulameen Platinum Project. The presence of high-value minerals such as nickel, cobalt, and platinum group metals aligns with global demand for these resources, driven by their critical role in battery technology, electric vehicles, and various industrial applications. The company plans to build on these findings by conducting further exploration and development activities. This will include detailed geological mapping, additional sampling, and possibly drilling to better delineate the extent of the mineralization and to define a resource estimate. The historical data combined with the recent assay results provide a robust foundation for future work. #proactiveinvestors #northbayresourcesinc #otc #nbri #mining #bishopgoldmill #Mining #Exploration #TulaMine #BritishColumbia #Nickel #Cobalt #Copper #Platinum #ResourceEstimation #MineralDeposits #GeochemicalAnalysis #HistoricalMining #MassTonnage #SulfideDeposits #MiningHistory #CEOUpdate #JaredLazerson #MiningProjects #FutureExploration #NaturalResources #invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews

Every Podcast » Proactive - Interviews for investors » Orthocell reports 98.6% success rate in Striate+™ dental membrane study